Building on discoveries from Nobel Laureate Professor Jennifer Doudna’s CRISPR lab, Algen Biotechnologies is creating a new way to discover medicines that could change the course of diseases with high unmet needs
Algen originated from the laboratory of UC Berkeley Professor
AlgenCRISPR is a proprietary, next-generation CRISPR system. Our best-in-class technology offers robust, fine-tuned and precise gene modulation to deconvolute complex biology. AlgenCRISPR powers the AlgenBrainTM platform to industrialize single-cell gene modulation driving towards impactful human-centric therapeutic endpoints.
AlgenBrain’s proprietary deep learning models are built on billions of real-time, dynamic gene expression changes that occur throughout disease progression. Our unique expertise is essential to handle the enormous, complex human-centric datasets and multi hundred-thousand gene modulated cell fates we generate to illuminate disease-driving RNA signaling pathways and extract the most important insights for drug discovery.
Discover More About Algen Bio
